Marshall Wace’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.8M | Buy |
2,704,837
+2,681,263
| +11,374% | +$46.4M | 0.05% | 283 |
|
|
2025
Q1 | $516K | Sell |
23,574
-61,921
| -72% | -$1.35M | ﹤0.01% | 1955 |
|
|
2024
Q4 | $2.73M | Buy |
85,495
+63,705
| +292% | +$2.03M | ﹤0.01% | 1222 |
|
|
2024
Q3 | $628K | Buy |
+21,790
| New | +$628K | ﹤0.01% | 1707 |
|
|
2024
Q2 | – | Sell |
-171,873
| Closed | -$10.1M | – | 2278 |
|
|
2024
Q1 | $10.1M | Sell |
171,873
-59,003
| -26% | -$3.47M | 0.02% | 657 |
|
|
2023
Q4 | $13.8M | Buy |
230,876
+61,582
| +36% | +$3.69M | 0.02% | 500 |
|
|
2023
Q3 | $6.44M | Sell |
169,294
-173,058
| -51% | -$6.58M | 0.01% | 712 |
|
|
2023
Q2 | $31.2M | Buy |
342,352
+249,906
| +270% | +$22.8M | 0.06% | 299 |
|
|
2023
Q1 | $6.1M | Sell |
92,446
-343,977
| -79% | -$22.7M | 0.01% | 764 |
|
|
2022
Q4 | $22.6M | Buy |
436,423
+99,696
| +30% | +$5.16M | 0.05% | 361 |
|
|
2022
Q3 | $23M | Sell |
336,727
-1,031,680
| -75% | -$70.5M | 0.05% | 368 |
|
|
2022
Q2 | $61.9M | Buy |
1,368,407
+453,244
| +50% | +$20.5M | 0.13% | 146 |
|
|
2022
Q1 | $46.5M | Buy |
+915,163
| New | +$46.5M | 0.09% | 228 |
|
|
2021
Q3 | – | Sell |
-10,375
| Closed | -$656K | – | 2373 |
|
|
2021
Q2 | $656K | Buy |
+10,375
| New | +$656K | ﹤0.01% | 1559 |
|
|
2019
Q1 | – | Sell |
-3,382
| Closed | -$45K | – | 1687 |
|
|
2018
Q4 | $45K | Buy |
+3,382
| New | +$45K | ﹤0.01% | 1450 |
|